PRECISIONheor Earns the GRASP Advocate Choice Award

We are honored to announce that PRECISIONheor earned the GRASP Advocate Choice Award at SABCS for our poster, "Understanding Clinical Meaningfulness in Metastatic Breast Cancer Treatment Decision-Making: Experiences and Perspectives of Patients, Caregivers, and Clinicians." The award is granted by patients to posters that most advance and highlight the needs of metastatic breast cancer patients. Only 15 posters are awarded this designation by the group.

LEARN MORE

PRECISIONheor Earns the GRASP Advocate Choice Award2023-12-18T11:29:04-05:00

Poster Presentation: San Antonio Breast Cancer Symposium (SABCS) 2023

Gilead Sciences, Inc. will present new data at the San Antonio Breast Cancer Symposium (SABCS) 2023 supporting the use of Trodelvy® (sacituzumab govitecan-hziy) in certain metastatic triple-negative breast cancer (mTNBC) and pre-treated HR+/HER2- metastatic breast cancer (mBC) patients. Precision's research with Gilead Sciences on "Understanding Clinical Meaningfulness in Metastatic Breast Cancer Treatment Decision-Making" will be presented during Poster Session 1: Poster # PO1-10-06 on Wednesday, Dec. 6 at 12:00 PM. Co-authored by Meaghan Roach, Rozanne Wilson, Suepattra May-Slater, Melissa Maravic and Emily Freeman.

LEARN MORE

Poster Presentation: San Antonio Breast Cancer Symposium (SABCS) 20232023-12-08T08:17:26-05:00
Precision Medicine Group

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

© Precision Medicine Group, LLC. All Rights Reserved.   Privacy | GDPR